Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions

E. Giarnieri, S. Mariotta, G. De Francesco, A. Ricci, D. Silvestri, M. R. Giovagnoli (Rome, Italy)

Source: Annual Congress 2007 - Pleural malignancy
Session: Pleural malignancy
Session type: Oral Presentation
Number: 4453
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Giarnieri, S. Mariotta, G. De Francesco, A. Ricci, D. Silvestri, M. R. Giovagnoli (Rome, Italy). Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions. Eur Respir J 2007; 30: Suppl. 51, 4453

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Effect of sampling phase of pleural fluid on the abundance of malignant cells in cytologic smears of effusions due to adenocarcinoma
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009



Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Quick immunohistochemical diagnosis of neoplasia pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006

Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007

Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Closed pleural brushing in the diagnosis of malignant pleural effusions
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009


Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006

Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010